PL3148990T3 - Związki tiazolidynonu i ich zastosowanie w leczeniu zaburzeń psychiatrycznych neurologicznych i stanów zapalnych, w szczególności stanów zapalnych układu nerwowego - Google Patents
Związki tiazolidynonu i ich zastosowanie w leczeniu zaburzeń psychiatrycznych neurologicznych i stanów zapalnych, w szczególności stanów zapalnych układu nerwowegoInfo
- Publication number
- PL3148990T3 PL3148990T3 PL15725042T PL15725042T PL3148990T3 PL 3148990 T3 PL3148990 T3 PL 3148990T3 PL 15725042 T PL15725042 T PL 15725042T PL 15725042 T PL15725042 T PL 15725042T PL 3148990 T3 PL3148990 T3 PL 3148990T3
- Authority
- PL
- Poland
- Prior art keywords
- psychiatric
- inflammation
- treatment
- neurological disorders
- thiazolidinone compounds
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title 1
- 208000012902 Nervous system disease Diseases 0.000 title 1
- 208000036110 Neuroinflammatory disease Diseases 0.000 title 1
- 208000025966 Neurological disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 230000003959 neuroinflammation Effects 0.000 title 1
- 208000020016 psychiatric disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14170449 | 2014-05-28 | ||
| EP14171024 | 2014-06-03 | ||
| EP15725042.4A EP3148990B1 (en) | 2014-05-28 | 2015-05-28 | Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation |
| PCT/EP2015/061915 WO2015181337A1 (en) | 2014-05-28 | 2015-05-28 | Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3148990T3 true PL3148990T3 (pl) | 2022-05-30 |
Family
ID=54698145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15725042T PL3148990T3 (pl) | 2014-05-28 | 2015-05-28 | Związki tiazolidynonu i ich zastosowanie w leczeniu zaburzeń psychiatrycznych neurologicznych i stanów zapalnych, w szczególności stanów zapalnych układu nerwowego |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10155754B2 (pl) |
| EP (2) | EP4011879A1 (pl) |
| JP (1) | JP6671301B2 (pl) |
| CN (1) | CN106660976B (pl) |
| AU (2) | AU2015265865C1 (pl) |
| BR (1) | BR112016027901B1 (pl) |
| CA (1) | CA2950354C (pl) |
| DK (1) | DK3148990T3 (pl) |
| ES (1) | ES2910455T3 (pl) |
| HR (1) | HRP20220490T8 (pl) |
| MX (2) | MX378165B (pl) |
| PL (1) | PL3148990T3 (pl) |
| RS (1) | RS63107B1 (pl) |
| RU (1) | RU2734253C2 (pl) |
| WO (1) | WO2015181337A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3148541B1 (en) * | 2014-05-28 | 2020-09-02 | Universität Bern | Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation |
| EP4713314A1 (en) | 2023-05-19 | 2026-03-25 | Universität Bern | A binding site to prevent endocannabinoid cellular reuptake |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2798067A (en) * | 1954-03-29 | 1957-07-02 | Eastman Kodak Co | 2-imino-4-thiazolidones and preparation |
| US2739888A (en) * | 1954-03-29 | 1956-03-27 | Eastman Kodak Co | Photographic elements containing thiazolidine derivatives |
| EP1567112B1 (en) * | 2002-11-22 | 2008-10-15 | Smithkline Beecham Corporation | THIAZOLIDIN-4-ONES FOR INHIBITING hYAK3 PROTEINS |
| AU2004264354A1 (en) * | 2003-08-12 | 2005-02-24 | Amgen Inc. | Arylsulfonamidobenzylic compounds |
| EP1654380A4 (en) * | 2003-08-14 | 2009-09-09 | Insight Biopharmaceuticals Ltd | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING HEPARANASE ACTIVATION AND USES THEREOF |
| AU2004295047B2 (en) | 2003-11-21 | 2011-03-10 | Laboratoires Juvise Pharmaceuticals | 5-(benz- (Z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents |
| EP2298308B1 (en) * | 2005-11-14 | 2013-01-16 | University Of Southern California | Integrin-binding small molecules |
| WO2008100977A2 (en) * | 2007-02-14 | 2008-08-21 | N.V. Organon | Carbamates therapeutic release agents as amidase inhibitors |
| WO2009137133A2 (en) * | 2008-02-14 | 2009-11-12 | University Of Washington | 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection |
| ES2557314T3 (es) | 2009-05-29 | 2016-01-25 | Dr. August Wolff Gmbh & Co. Kg Arzneimittel | Dodeca-2E,4E-dieno amidas y sus usos como medicamentos y cosméticos |
| GB201007187D0 (en) * | 2010-04-29 | 2010-06-09 | Iti Scotland Ltd | Ubiquitination modulators |
-
2015
- 2015-05-28 CA CA2950354A patent/CA2950354C/en active Active
- 2015-05-28 RS RS20220349A patent/RS63107B1/sr unknown
- 2015-05-28 EP EP22152116.4A patent/EP4011879A1/en active Pending
- 2015-05-28 EP EP15725042.4A patent/EP3148990B1/en active Active
- 2015-05-28 WO PCT/EP2015/061915 patent/WO2015181337A1/en not_active Ceased
- 2015-05-28 US US15/314,067 patent/US10155754B2/en active Active
- 2015-05-28 RU RU2016147230A patent/RU2734253C2/ru active
- 2015-05-28 PL PL15725042T patent/PL3148990T3/pl unknown
- 2015-05-28 ES ES15725042T patent/ES2910455T3/es active Active
- 2015-05-28 HR HRP20220490TT patent/HRP20220490T8/hr unknown
- 2015-05-28 CN CN201580040087.8A patent/CN106660976B/zh active Active
- 2015-05-28 DK DK15725042.4T patent/DK3148990T3/da active
- 2015-05-28 AU AU2015265865A patent/AU2015265865C1/en active Active
- 2015-05-28 BR BR112016027901-8A patent/BR112016027901B1/pt active IP Right Grant
- 2015-05-28 JP JP2016569730A patent/JP6671301B2/ja active Active
- 2015-05-28 MX MX2016015627A patent/MX378165B/es unknown
-
2016
- 2016-11-28 MX MX2020013537A patent/MX2020013537A/es unknown
-
2018
- 2018-12-17 US US16/221,634 patent/US10392377B2/en active Active
-
2019
- 2019-08-21 US US16/546,328 patent/US10774077B2/en active Active
-
2020
- 2020-08-06 AU AU2020213369A patent/AU2020213369B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289650A (en) | Azolopyrimidine for the treatment of cancer-related disorders | |
| HRP20210518T1 (hr) | Derivati 2,4-tiazolidindiona, namijenjeni liječenju poremećaja središnjeg živčanog sustava | |
| IL259751B (en) | Polycyclic compounds and their use in the treatment of immune disorders | |
| SG11201607705XA (en) | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders | |
| GB2542155B (en) | Use of cannabidiol in the treatment of mental disorders | |
| IL258032B (en) | Compounds and preparations for the treatment of ocular disorders | |
| PT3160464T (pt) | 6-hidroxibuspirona para uso no tratamento de transtornos do movimento | |
| IL275349A (en) | Use of hM4Di in the treatment of seizure disorders | |
| IL246855A0 (en) | Materials for use in the treatment of retinitis | |
| IL274838A (en) | Use of MIR101 or MIR128 in the treatment of seizure disorders | |
| EP3371154A4 (en) | HETEROCYCLIC DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CNS DISORDERS | |
| HRP20220490T8 (hr) | Spojevi tiazolidinona i njihova upotreba u liječenju psihijatrijskih ili neuroloških poremećaja i inflamacije, posebno neuroinflamacije | |
| IL259383A (en) | A compound for use in the prevention and treatment of neurodegenerative diseases | |
| ZA201806894B (en) | (+)-azasetron for use in the treatment of ear disorders | |
| PT3148990T (pt) | Compostos de tiazolidinona e seu uso no tratamento de condições psiquiátricas ou distúrbios neurológicos e inflamação, particularmente neuroinflamação | |
| GB201603510D0 (en) | Compositions for use in the treatment of neurological disease | |
| PT3442537T (pt) | (+)-azasetrom para utilização no tratamento de doenças do ouvido | |
| HK1260601A1 (en) | Heterocycle derivatives and their use for the treatment of cns disorders | |
| PT3370727T (pt) | Derivados da pregnenolona substituídos em c3 não bioconvertíveis para utilização no tratamento de distúrbios de toxicodependência |